WCMNY
AMED

Westchester Capital Management (New York)’s Amedisys AMED Stock Holding History

Westchester Capital Management (New York)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-154,583
Closed -$15.2M – 259
2025
Q2 		$15.2M Buy
154,583
+15,842
+11% +$1.5M 0.8% 23
2025
Q1 		$12.9M Sell
138,741
-51,103
-27% -$4.71M 0.66% 29
2024
Q4 		$17.2M Sell
189,844
-928,958
-83% -$85.3M 0.94% 25
2024
Q3 		$108M Buy
1,118,802
+97,476
+10% +$9.51M 4.61% 6
2024
Q2 		$93.8M Buy
1,021,326
+40,269
+4% +$3.74M 3.52% 6
2024
Q1 		$90.4M Buy
981,057
+101,655
+12% +$9.53M 3.32% 6
2023
Q4 		$83.6M Buy
879,402
+29,016
+3% +$2.71M 2.93% 8
2023
Q3 		$79.4M Buy
850,386
+620,386
+270% +$57.3M 2.32% 8
2023
Q2 		$21M Buy
+230,000
New +$18.9M 0.66% 29

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Westchester Capital Management (New York)'s AMED Position: Q3 2025 in Review

Westchester Capital Management (New York) sold out of Amedisys (AMED) in Q3 2025, closing a stake of 154,583 shares — an estimated $15.2M sold.

Westchester Capital Management (New York) first reported a position in AMED in Q2 2023 and held it in 9 quarters. The position peaked at $108M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Westchester Capital Management (New York) reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 154,583 Amedisys shares in Q3 2025, an estimated $15.2M.
  • Westchester Capital Management (New York) first reported a position in Amedisys in Q2 2023 and held it in 9 quarters.
  • Westchester Capital Management (New York)'s Amedisys position peaked at $108M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2025, filed 14 Nov 2025.